Literature DB >> 20083538

Spinal inflammation lesions as detected by magnetic resonance imaging in patients with early ankylosing spondylitis are more often observed in posterior structures of the spine.

Anna G Bochkova1, Antonina V Levshakova, Nicholay V Bunchuk, Jurgen Braun.   

Abstract

OBJECTIVE: To study the localization and extent of spinal inflammation in patients with AS in detail.
METHODS: This cross-sectional study used standardized clinical tools and MRI, including T1 and T2 fat saturation sequences in both sagittal and axial planes. A simple method of analysis of MRI changes was performed using the principle of 'yes/no' to calculate the changes in vertebral body and posterior structures of spine, including costovertebral and costotransversal joints.
RESULTS: Consecutive patients with AS (n = 29), who fulfilled the modified NY criteria, were examined by MRI: 67% male, 93% HLA-B27-positive, median age 27.5 (18-49) years, median disease duration 7.5 (1.5-24) years. Inflammatory back pain (IBP), median duration 36 (1-240) months, with a mean intensity of 40 mm on a visual analogue scale (20-100) was present in 26 patients (89.7%), and the Bath AS Disease Activity Index (BASDAI) was > 40 in 21 patients (72.4%). MRI evidence of spinal inflammation at any site was found in 27 patients (96.5%), whereas radiographic changes were only seen in 6.9% (P < 0.05). Patients with a short history of IBP (n = 11) had significantly more lesions in posterior spinal structures than in vertebral bodies: 90.9 vs 27.2%, respectively (P < 0.003). Isolated changes in posterior spinal structures were seen in eight of these patients (72.7%), whereas, in contrast, patients with a longer history of IBP (n = 18) had significantly more inflammation in vertebral bodies: 88.9 vs 27.2%, respectively (P < 0.01).
CONCLUSIONS: Inflammatory MRI lesions in early AS are seen more often in posterior structures of the spine. This may be relevant for the diagnosis of early AS and the early detection of inflammatory spinal involvement.

Entities:  

Mesh:

Year:  2010        PMID: 20083538     DOI: 10.1093/rheumatology/kep419

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  13 in total

1.  Ankylosing spondylitis - the changing role of imaging.

Authors:  Zoe Ash; Helena Marzo-Ortega
Journal:  Skeletal Radiol       Date:  2012-09       Impact factor: 2.199

2.  Prevalence of inflammatory posterior arch abnormalities on lumbar spine MRI in spondyloarthritis patients compared with low back pain patients.

Authors:  Hélène Braun; Clément Geniez; Yannick Degboe; Arnaud Constantin; Alain Cantagrel; Delphine Nigon; Nicolas Sans; Marie Faruch-Bilfeld; Adeline Ruyssen-Witrand
Journal:  Eur Radiol       Date:  2019-05-22       Impact factor: 5.315

3.  Assessment of therapeutic response in ankylosing spondylitis patients undergoing anti-tumour necrosis factor therapy by whole-body magnetic resonance imaging.

Authors:  Martina Karpitschka; Patrizia Godau-Kellner; Herbert Kellner; Annie Horng; Daniel Theisen; Christian Glaser; Bernhard Brandlhuber; Maximilian Reiser; Sabine Weckbach
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

4.  Bone edema of the whole vertebral body: an unusual case of spondyloarthritis.

Authors:  Augusta Ortolan; Paolo Lazzarin; Mariagrazia Lorenzin; Lucia Rampin; Roberta Ramonda
Journal:  Clin Rheumatol       Date:  2016-09-27       Impact factor: 2.980

Review 5.  Juvenile spondyloarthropathies.

Authors:  R Hal Scofield; Andrea L Sestak
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

Review 6.  Treat-to-target in axial spondyloarthritis - what about physical function and activity?

Authors:  Jürgen Braun; Xenofon Baraliakos; Uta Kiltz
Journal:  Nat Rev Rheumatol       Date:  2021-07-26       Impact factor: 20.543

Review 7.  Better Quantification of Syndesmophyte Growth in Axial Spondyloarthritis.

Authors:  Michael M Ward; Sovira Tan
Journal:  Curr Rheumatol Rep       Date:  2018-06-21       Impact factor: 4.592

Review 8.  A systematic critical review on MRI in spondyloarthritis.

Authors:  Bodil Arnbak; Charlotte Leboeuf-Yde; Tue Secher Jensen
Journal:  Arthritis Res Ther       Date:  2012-03-09       Impact factor: 5.156

9.  Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial.

Authors:  I-H Song; Kg Hermann; H Haibel; C E Althoff; Ce Althoff; J Listing; Gr Burmester; A Krause; M Bohl-Bühler; B Freundlich; M Rudwaleit; J Sieper
Journal:  Ann Rheum Dis       Date:  2011-04       Impact factor: 19.103

10.  The Anthropometric Measurement of Schober's Test in Normal Taiwanese Population.

Authors:  Yong-Ren Yen; Jin-Fan Luo; Ming-Li Liu; Fung-Jou Lu; Soo-Ray Wang
Journal:  Biomed Res Int       Date:  2015-07-27       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.